The Ras branch of small GTPases: Ras family members don't fall far from the tree

Current Opinion in Cell Biology

Volumn 12, Issue 2, 2000, Pages 157-165

  Reuther, Gary W ^a   Der, Channing J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; RAS PROTEIN;

AMINO ACID SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; GTP PHOSPHOHYDROLASES; HUMANS; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 0034104590     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)00071-X     Document Type: Review

References (83)

1. Marshall C.J. Ras effectors. Curr Opin Cell Biol. 8:1996;197-204.
2. Campbell S.L., Khosravi-Far R., Rossman K.L., Clark G.J., Der C.J. Increasing complexity of Ras signaling. Oncogene. 17:1998;1395-1413.
3. Van Aelst L., D'Souza-Schorey C. Rho GTPases and signaling networks. Genes Dev. 11:1997;2295-2322.
4. Zohn I.M., Campbell S.L., Khosravi-Far R., Rossman K.L., Der C.J. Rho family proteins and Ras transformation: the RHOad less traveled gets congested. Oncogene. 17:1998;1415-1438.
5. Umanoff H., Edelmann W., Pellicer A., Kucherlapati R. The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA. 92:1995;1709-1713.
6. Johnson L., Greenbaum D., Cichowski K., Mercer K., Murphy E., Schmitt E., Bronson R.T., Umanoff H., Edelmann W., Kucherlapati R.et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev. 11:1997;2468-2481.
7. Cox A.D., Der C.J. Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? Biochim Biophys Acta. 1333:1997;51-71.
8. Oliff A. Farnesyltransferase inhibitors: targeting the molecular basis of cancer. Biochim Biophys Acta. 1423:1999;19-30.
9. Dai Q., Choy E., Chiu V., Romano J., Slivka S.R., Steitz S.A., Michaelis S., Philips M.R. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J Biol Chem. 273:1998;15030-15034.
10. Romano J.D., Schmidt W.K., Michaelis S. The Saccharomyces cerevisiae prenylcysteine carboxyl methyltransferase Ste14p is in the endoplasmic reticulum membrane. Mol Biol Cell. 9:1998;2231-2247.
11. Schmidt W.K., Tam A., Fujimura-Kamada K., Michaelis S. Endoplasmic reticulum membrane localization of Rce1p and Ste24p, yeast proteases involved in carboxyl-terminal CAAX protein processing and amino-terminal a-factor cleavage. Proc Natl Acad Sci USA. 95:1998;11175-11180.
12. ras to the plasma membrane. Cell. 63:1990;133-139.
13. Choy E., Chiu V.K., Silletti J., Feoktistov M., Morimoto T., Michaelson D., Ivanov I.E., Philips M.R. Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell. 98:1999;69-80. Although it had been known that Ras proteins required the CAAX motif and a second signal in the hypervariable region to be properly localized at the plasma membrane, this work shows that the CAAX motif alone is sufficient to localize protein to the endomembrane system, and the second signal in the Ras hypervariable region is required for transit to the plasma membrane. It was also shown that H-Ras and K-Ras4B take slightly different routes to the plasma membrane.
14. Roy S., Luetterforst R., Harding A., Apolloni A., Etheridge M., Stang E., Rolls B., Hancock J.F., Parton R.G. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat Cell Biol. 1:1999;98-105. This study analyzes the effect of a dominant negative caveolin on Ras signaling. The authors suggest that K-Ras4B and H-Ras function in distinct microdomains within the plasma membrane.
15. Simons K., Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
16. Anderson R.G. The caveolae membrane system. Annu Rev Biochem. 67:1998;199-225.
17. ••], this report indicates that caveolin plays an important role in Ras signaling.
18. Church D.L., Guan K.L., Lambie E.J. Three genes of the MAP kinase cascade, mek-2, mpk-1/sur-1 and let-60 ras, are required for meiotic cell cycle progression in Caenorhabditis elegans. Development. 121:1995;2525-2535.
19. Yan J., Roy S., Apolloni A., Lane A., Hancock J.F. Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem. 273:1998;24052-24056. Although specific differences in signaling by the different Ras isoforms have been difficult to demonstrate, this report indicates that K-Ras activates Raf better than H-Ras. H-Ras was shown to be a better activator of PI 3-kinase than K-Ras.
20. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385:1997;544-548.
21. Mayo M.W., Wang C-Y., Cogswell P.C., Rogers-Graham K.S., Lowe S.W., Der C.J., Baldwin A.S. Jr. Requirement, of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science. 278:1997;1812-1815.
22. Feig L.A. Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat Cell Biol. 1:1999;25-27.
23. Graham S.M., Cox A.D., Drivas G., Rush M.R., D'Eustachio P., Der C.J. Aberrant function of the Ras-related TC21/R-Ras2 protein triggers malignant transformation. Mol Cell Biol. 14:1994;4108-4115.
24. Graham S.M., Vojtek A.B., Huff S.Y., Cox A.D., Clark G.J., Cooper J.A., Der C.J. TC21 causes transformation by Raf-independent signaling pathways. Mol Cell Biol. 16:1996;6132-6140.
25. Rosario M., Paterson H.F., Marshall C.J. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. EMBO J. 18:1999;1270-1279.
26. Zhu J., Woods D., McMahon M., Bishop J.M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:1998;2997-3007.
27. Lin A.W., Barradas M., Stone J.C., Van Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:1998;3008-3019.
28. Chan A.M.L., Miki T., Meyers K.A., Aaronson S.A. A human oncogene of the ras superfamily unmasked by expression cDNA cloning. Proc Natl Acad Sci USA. 91:1994;7558-7562.
29. Huang Y., Saez R., Chao L., Santos E., Aaronson S.A., Chan A.M. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene. 11:1995;1255-1260.
30. Barker K.T., Crompton M.R. Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. Br J Cancer. 78:1998;296-300.
31. Wang H-G., Millan J.A., Cox A.D., Der C.J., Rapp U.R., Beck T., Reed J.C. R-Ras accelerates apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J Cell Biol. 129:1995;1103-1114.
32. Zhang Z., Vuori K., Wang H-G., Reed J.C., Ruoslahti E. Integrin activation by R-Ras. Cell. 85:1996;61-69.
33. Hughes P.E., Renshaw M.W., Pfaff M., Forsyth J., Keivens V.M., Schwartz M.A., Ginsberg M.H. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell. 88:1997;521-530.
34. Marte B.M., Rodriguez-Viciana P., Wennström S., Warne P.H., Downward J. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr Biol. 7:1996;63-70.
35. Urano T., Emkey R., Feig L.A. Ral-GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. EMBO J. 15:1996;810-816.
36. Matsumoto K., Asano T., Endo T. Novel small GTPase M-Ras participates in reorganization of actin cytoskeleton. Oncogene. 15:1997;2409-2417.
37. Kimmelman A., Tolkacheva T., Lorinzi M.V., Osada M., Chan A.M.L. Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution. Oncogene. 15:1997;2675-2685.
38. Quilliam L.A., Castro A.F., Rogers-Graham K.S., Martin C.B., Der C.J., Bi C. M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J Biol Chem. 274:1999;23850-23857. This study analyzes the transforming and signaling properties of M-Ras, showing that M-Ras transforms NIH3T3 cells while only weakly activating known Ras effector pathways.
39. Ehrhardt G.R., Leslie K.B., Lee F., Wieler J.S., Schrader J.W. M-Ras, a widely expressed 29-kD homologue of p21 ras: expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line. Blood. 94:1999;2433-2444.
40. Louahed J., Grasso L., De Smet C., Van Roost E., Wildmann C., Nicolaides N.C., Levitt R.C., Renauld J.C. Interleukin-9-induced expression of M-Ras/R-Ras3 oncogene in T-helper clones. Blood. 94:1999;1701-1710.
41. Kitayama H., Sugimoto Y., Matsuzaki T., Ikawa Y., Noda M. A ras-related gene with transformation suppressor activity. Cell. 56:1989;77-84.
42. Zwartkruis F.J., Bos J.L. Signal transduction. Rhapsody in G proteins. Nature. 400:1999;820-821.
43. Boussiotis V.A., Freeman G.J., Berezovskaya A., Barber D.L., Nadler L.M. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science. 278:1997;124-128.
44. Okada S., Matsuda M., Anafi M., Pawson T., Pessin J.E. Insulin regulates the dynamic balance between Ras and Rap1 signaling by coordinating the assembly states of the Grb2-SOS and CrkII-C3G complexes. EMBO J. 17:1998;2554-2565.
45. Beranger F., Goud B., Tavitian A., De Gunzburg J. Association of the Ras-antagonistic Rap1/Krev-1 proteins with the Golgi complex. Proc Natl Acad Sci USA. 88:1991;1606-1610.
46. Zwartkruis F.J., Wolthuis R.M., Nabben N.M., Franke B., Bos J.L. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling. EMBO J. 17:1998;5905-5912. Although it has been thought that Rap1 antagonizes Ras signaling, this report indicates that extracellular signals that activate Ras also activate Rap1. Rap1 activation failed to block Ras-mediated ERK activation, suggesting that Rap1 does not simply function as an inhibitor of Ras signals and might, therefore, have distinct functions in response to extracellular signals.
47. Serebriiskii I., Estojak J., Sonoda G., Testa J.R., Golemis E.A. Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat- containing protein encoded by a gene mapping to 7q21-22. Oncogene. 15:1997;1043-1049.
48. Hu C.D., Kariya K., Okada T., Qi X., Song C., Kataoka T. Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation. J Biol Chem. 274:1999;48-51.
49. +-mediated activation of Rap1 in human platelets. EMBO J. 16:1997;252-259.
50. M'Rabet L., Coffer P., Zwartkruis F., Franke B., Segal A.W., Koenderman L., Bos J.L. Activation of the small GTPase rap1 in human neutrophils. Blood. 92:1998;2133-2140.
51. Mcleod S.J., Ingham R.J., Bos J.L., Kurosaki T., Gold M.R. Activation of the Rap1 GTPase by the B cell antigen receptor. J Biol Chem. 273:1998;29218-29223.
52. Reedquist K.A., Bos J.L. Costimulation through CD28 suppresses T cell receptor-dependent activation of the Ras-like small GTPase Rap1 in human T lymphocytes. J Biol Chem. 273:1998;4944-4949.
53. •] describe the cloning of Epac, or cAMP-GEFI, and cAMP-GEFII, which are novel guanine nucleotide exchange factors for Rap1. These proteins couple signals that use cAMP as a second messenger to Rap1 activation.
54. •].
55. Kawasaki H., Springett G.M., Toki S., Canales J.J., Harlan P., Blumenstiel J.P., Chen E.J., Bany I.A., Mochizuki N., Ashbacher A.et al. A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci USA. 95:1998;13278-13283. This study describes the cloning of CalDAG-GEFI, a novel GEF for Rap1. This protein can activate Rap1 in response to an increase in calcium and diacyglycerol. This may be the mechanism of the previously observed activation of Rap1 by calcium and diacylglycerol.
56. •] characterize RasGRP, a recently identified Ras GEF that is regulated by diacylglycerol. The related CalDAG-GEFI is an activator of Rap1 that is regulated by diacyglycerol and calcium. Together these proteins provide mechanisms by which both Ras and Rap1 can be activated by the same stimuli.
57. •].
58. Ichiba T., Hoshi Y., Eto Y., Tajima N., Kuraishi Y. Characterization of GFR, a novel guanine nucleotide exchange factor for Rap1. FEBS Lett. 457:1999;85-89.
59. Ohtsuka T., Hata Y., Ide N., Yasuda T., Inoue E., Inoue T., Mizoguchi A., Takai Y. nRap GEP: a novel neural GDP/GTP exchange protein for Rap1 small G protein that interacts with synaptic scaffolding molecule (S-SCAM). Biochem Biophys Res Commun. 265:1999;38-44.
60. Ichiba T., Hashimoto Y., Nakaya M., Kuraishi Y., Tanaka S., Kurata T., Mochizuki N., Matsuda M. Activation of C3G guanine nucleotide exchange factor for Rap1 by phosphorylation of tyrosine 504. J Biol Chem. 274:1999;14376-14381.
61. Wolthuis R.M., Bos J.L. Ras caught in another affair: the exchange factors for Ral. Curr Opin Genet Dev. 9:1999;112-117.
62. Aguirre-Ghiso J.A., Frankel P., Farias E.F., Lu Z., Jiang H., Olsen A., Feig L.A., De Kier J., Foster D.A. RalA requirement for v-src- and v-ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases. Oncogene. 18:1999;4718-4725.
63. Goi T., Rusanescu G., Urano T., Feig L.A. Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth. Mol Cell Biol. 19:1999;1731-1741. The Ral pathway is believed to play an important role downstream of Ras signaling and can cooperate with other Ras effector pathways to transform cells. This work shows that the Ral pathway antagonizes Ras and NGF-mediated differentiation of PC12 cells, suggesting the effect of activation of the Ral pathway might be cell-type specific.
64. +-dependent pathway. Curr Biol 1998. 8:0042;839-842.
65. +/calmodulin stimulates GTP binding to the ras-related protein ral-A. J Biol Chem 1999. 274:0042;14525-14528.
66. White M.A., Vale T., Camonis J.H., Schaefer E., Wigler M.H. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J Biol Chem. 271:1996;16439-16442.
67. Rodriguez-Viciana P., Warne P.H., Khwaja A., Marte B.M., Pappin D., Das P., Waterfield M.D., Ridley A., Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:1997;457-467.
68. Khosravi-Far R., White M.A., Westwick J.K., Solski P.A., Chrzanowska-Wodnicka M., Van Aelst L., Wigler M.H., Der C.J. Oncogenic Ras activation of Raf/MAP kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol. 16:1996;3923-3933.
69. Webb C.P., Van Aelst L., Wigler M.H., Woude G.F. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci USA. 95:1998;8773-8778.
70. Okazaki M., Kishida S., Hinoi T., Hasegawa T., Tamada M., Kataoka T., Kikuchi A. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator. Oncogene. 14:1997;515-521.
71. Murai H., Ikeda M., Kishida S., Ishida O., Okazaki-Kishida M., Matsuura Y., Kikuchi A. Characterization of Ral GDP dissociation stimulator-like (RGL) activities to regulate c-fos promoter and the GDP/GTP exchange of Ral. J Biol Chem. 272:1997;10483-10490.
72. Wolthuis R.M., De Ruiter N.D., Cool R.H., Bos J.L. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:1997;6748-6761.
73. Gille H., Downward J. Multiple ras effector pathways contribute to G(1) cell cycle progression. J Biol Chem. 274:1999;22033-22040.
74. Kops G.J., De Ruiter N.D., De Vries-Smits A.M., Powell D.R., Bos J.L., Burgering B.M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature. 398:1999;630-634.
75. Nakashima S., Morinaka K., Koyama S., Ikeda M., Kishida M., Okawa K., Iwamatsu A., Kishida S., Kikuchi A. Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J. 18:1999;3629-3642.
76. Yamagata K., Sanders L.K., Kaufmann W.E., Yee W., Barnes C.A., Nathans D., Worley P.F. rheb, a growth factor-and synaptic activity-regulated gene, encodes a novel Ras-related protein. J Biol Chem. 269:1994;16333-16339.
77. Kinouchi H., Arai S., Kamii H., Izaki K., Kunizuka H., Mizoi K., Yoshimoto T. Induction of Rheb mRNA following middle cerebral artery occlusion in the rat. Neuroreport. 10:1999;1055-1059.
78. Clark G.J., Kinch M.S., Rogers-Graham K., Sebti S.M., Hamilton A.D., Der C.J. The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. J Biol Chem. 272:1997;10608-10615.
79. Yee W.M., Worley P.F. Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals. Mol Cell Biol. 17:1997;921-933.
80. Urano J., Tabancay A.P., Yang W., Tamanoi F. The S. cerevisiae Rheb G-protein, ScRheb, is involved in regulating canavanine resistance and arginine uptake. J Biol Chem. 1999;. in press.
81. Lee C.H.J., Della N.G., Chew C.E., Zack D.J. Rin, a neuron-specific and calmodulin-binding small G-protein, and Rit define a novel subfamily of ras proteins. J Neurosci. 16:1996;6784-6794.
82. Wes P.D., Yu M., Montell C. RIC, a calmodulin-binding Ras-like GTPase. EMBO J. 15:1996;5839-5848.
83. Shao H., Kadono-Okuda K., Finlin B.S., Andres D.A. Biochemical characterization of the Ras-related GTPases Rit and Rin. Arch Biochem Biophys. 371:1999;207-219.